N-Benzylacetamidine hydrobromide is primarily utilized in organic synthesis as a key intermediate for the preparation of various biologically active compounds. Its structure, featuring an amidine group, makes it valuable in the development of pharmaceuticals, particularly in the synthesis of enzyme inhibitors and receptor antagonists. It is often employed in the production of compounds targeting cardiovascular diseases, inflammatory conditions, and central nervous system disorders. Additionally, its reactivity allows for its use in the creation of peptidomimetics, which are essential in drug discovery for mimicking peptide structures. The compound also finds application in research settings for studying molecular interactions and designing new therapeutic agents.